WebApr 14, 2024 · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. … Web20 hours ago · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. …
Cingulate Inc (CING) Stock Forecast, Price Targets and Analysts ...
WebGet the latest Cingulate Inc (CING) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebFeb 24, 2024 · Matthew Brams, MD, Cingulate Inc’s Chief Medical Officer, said: “CTx-1301 is being developed to provide the proven efficacy of stimulants while addressing the key challenges associated with available formulations, including sub-optimal onset and duration along with burdensome medication regimens which often lead to non-compliance, … chistlukeshealth.org
CING – Cingulate to Participate in Benzinga All Live Access Event
WebDec 31, 2024 · CING: Cingulate Inc. cash flow statements. Get the latest rcash flow statements from Zacks Investment Research. WebApr 4, 2024 · In addition to the Phase 3 adult dose-optimization study, Cingulate plans to commence its pivotal Phase 3 fixed-dose pediatric and adolescent study in mid-2024. Assuming positive clinical results from the Phase 3 trials, Cingulate plans to submit a New Drug Application (NDA) for CTx-1301 in the first half of 2024 under the Section 505(b)(2 ... WebCingulate Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Cingulate Inc. is a clinical-stage biopharmaceutical … chi st luke\u0027s billing department phone